Skip to main content
. 2015 Feb 19;8:451–460. doi: 10.2147/OTT.S71384

Figure 2.

Figure 2

Immunohistochemistry.

Notes: Case 1: (A) perivascular cell arrangement; H&E, 10×; (B) necrosis and polymorphic cells; H&E, 10×; (C) GFAP-positive perivascular cells; DAB, 10×; (D) Ki-67/MIB-1 LI; DAB, 20×. Case 2 (first intervention): (E) aspect of oligodendroglioma; H&E, 10×; (F) GFAP-negative palisades; DAB, 10×; (G) rhythms and palisades; H&E, 10×; (H) Ki-67/MIB-1 LI; DAB, 20×. Case 2 (second intervention): (I) perivascular arrangement of astrocytic cells; H&E, 20×; (J) id, H&E; 20×; (K) GFAP-positive perivascular cells; DAB, 20×; (L) Ki-67/MIB-1 LI; DAB, 10×. Case 3 (M) perivascular arrangement of large cells; H&E, 20×; (N) polymorphic cells and vessel hyalinization; H&E, 10×; (O) GFAP-positive perivascular cells; DAB, 20×; (P) Ki-67/MIB-1 LI; DAB, 20×.

Abbreviations: DAB, 3,3’-Diaminobenzidine; H&E, hematoxylin and eosin; LI, labeling index; id, perivascular arrangement of astrocytic cells.